JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Baka, N.-E. Articles by Laxenaire, M.-C. Search for Related Content PubMed PubMed Citation Articles by Baka, N.-E. Articles by Laxenaire, M.-C. Related Collections Pain Obstetrics

---

OBSTETRIC ANESTHESIA

Colostrum Morphine Concentrations During Postcesarean Intravenous Patient-Controlled Analgesia

Nour-Eddine Baka, MD^*, Françoise Bayoumeu, MD^*, Marie-Jeanne Boutroy, MD PhD, and Marie-Claire Laxenaire, MD PhD^*

*Department of Anesthesiology, and Clinical Pharmacology and Neonatal Intensive Care Unit, Maternité Régionale Universitaire, Nancy, France

Address correspondence and reprint requests to Nour-Eddine Baka, MD, Department of Anesthesiology, Maternité Régionale, 10 rue du Dr Heydenreich, BP 4213, 54042 Nancy cedex, France. Address e-mail to ne.baka{at}maternite.chu-nancy.fr

Patient-controlled analgesia (PCA) with morphine is a convenient method for providing postoperative analgesia. Despite the fact that it is used after cesarean delivery, data on transfer of morphine and of its active metabolite morphine-6 glucuronide (M6G) into maternal milk are scarce. It is not known whether breast-feeding during PCA with morphine has neonatal implications. We sought to measure morphine and M6G concentrations in colostrum during postpartum IV PCA and evaluate the potential for drug intake by neonates being breast-fed by these mothers. Seven informed and consenting mothers, given IV PCA with morphine, were investigated. Plasma and milk samples were obtained at titration, and at 12, 24, 36, and 48 h. Morphine and M6G were measured by high-performance liquid chromatography. In plasma, morphine concentrations ranged from <1 to 274 ng/mL, M6G ranged from <5 to 974 ng/mL. In milk, opioids were found in only 3 patients in whom morphine concentrations ranged from <1 to 48 ng/mL and M6G from <5 to 1084 ng/mL. The milk-to-plasma ratio was always <1 for morphine. In conclusion, we observed very small morphine and M6G concentrations in colostrum during PCA with morphine. Under these conditions, the amounts of drug likely to be transferred to the breast-fed neonate are negligible.

IMPLICATIONS: Colostrum concentrations of morphine and its active metabolite morphine-6 glucuronide were measured in mothers receiving patient-controlled analgesia with morphine after cesarean delivery. The concentrations were found to be very small, thus supporting the safety of breast-feeding in mothers receiving IV patient-controlled analgesia with morphine.

This article has been cited by other articles:

				J. Littleford Effects on the fetus and newborn of maternal analgesia and anesthesia: a review: [Les effets de l'analgesie et de l'anesthesie de la mere sur le foetus et le nouveau-ne: une revue] Can J Anesth, June 1, 2004; 51(6): 586 - 609. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999